drugset / Trial / NCT03849612
A Study of an Automated Insulin Delivery System in Adult Participants With Type 1 Diabetes Mellitus
NaSingle-groupOpen-labelDevice feasibility
Summary
The purpose of this study is to evaluate whether an Automated Insulin Delivery (AID) System is safe to use and functions as intended with personalized basal insulin rates and when basal insulin rates are increased.
Timeline
- Start
- 2019-02-21
- Primary completion
- 2019-03-27
- Completion
- 2019-03-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Insulin Lispro | Protein / enzyme biologic | — | Subcutaneous |